Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors
Authors:
- Stanley A ThayerSTStanley A Thayer
- 2 August 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 496 (1-3) , 33-39
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Brain monoglyceride lipase participating in endocannabinoid inactivationProceedings of the National Academy of Sciences, 2002
- Direct inhibition of T‐type calcium channels by the endogenous cannabinoid anandamideThe EMBO Journal, 2001
- Cannabinoid-receptor-independent cell signalling by N-acylethanolaminesBiochemical Journal, 2001
- How does calcium trigger neurotransmitter release?Current Opinion in Neurobiology, 2001
- AM-404 elevates renal intracellular Ca2+, questioning its selectivity as a pharmacological tool for investigating the anandamide transporterJournal of Pharmacological and Toxicological Methods, 2001
- Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activityFEBS Letters, 2000
- Reversal of Dopamine D2Receptor Responses by an Anandamide Transport InhibitorJournal of Neuroscience, 2000
- Control of pain initiation by endogenous cannabinoidsNature, 1998
- Potentiation of anandamide hypotension by the transport inhibitor, AM404European Journal of Pharmacology, 1997
- Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective InhibitionScience, 1997